- Home
- CLLS vs EML Comparison
CLLS vs EML Comparison
Compare CLLS & EML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- EML
- Stock Information
- Founded
- CLLS 1999
- EML 1858
- Country
- CLLS France
- EML United States
- Employees
- CLLS N/A
- EML N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- EML Industrial Machinery/Components
- Sector
- CLLS Health Care
- EML Consumer Discretionary
- Exchange
- CLLS Nasdaq
- EML Nasdaq
- Market Cap
- CLLS 144.4M
- EML 130.9M
- IPO Year
- CLLS 2007
- EML N/A
- Fundamental
- Price
- CLLS $1.58
- EML $22.66
- Analyst Decision
- CLLS Buy
- EML
- Analyst Count
- CLLS 3
- EML 0
- Target Price
- CLLS $7.00
- EML N/A
- AVG Volume (30 Days)
- CLLS 79.4K
- EML 13.5K
- Earning Date
- CLLS 05-27-2025
- EML 05-06-2025
- Dividend Yield
- CLLS N/A
- EML 1.94%
- EPS Growth
- CLLS N/A
- EML N/A
- EPS
- CLLS N/A
- EML N/A
- Revenue
- CLLS $49,217,000.00
- EML $271,440,503.00
- Revenue This Year
- CLLS $48.52
- EML N/A
- Revenue Next Year
- CLLS $5.17
- EML N/A
- P/E Ratio
- CLLS N/A
- EML $10.78
- Revenue Growth
- CLLS 435.38
- EML 8.15
- 52 Week Low
- CLLS $1.10
- EML $19.06
- 52 Week High
- CLLS $3.32
- EML $35.03
- Technical
- Relative Strength Index (RSI)
- CLLS 60.44
- EML 53.46
- Support Level
- CLLS $1.46
- EML $19.06
- Resistance Level
- CLLS $1.65
- EML $23.61
- Average True Range (ATR)
- CLLS 0.08
- EML 0.86
- MACD
- CLLS -0.00
- EML 0.55
- Stochastic Oscillator
- CLLS 75.00
- EML 79.12
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.